Not exact matches
Insurers like Anthem have refused to cover the exorbitantly pricey treatment (around $ 300,000) since the drug's label admits that Exondys hasn't proved its
efficacy, making the
therapy a roll
of the dice
for payers and patients alike.
The treatment was approved
for the devastating rare disease Duchenne muscular dystrophy but created major divisions within the FDA because it simply hadn't demonstrated a whole lot
of efficacy, meaning the pricey
therapy is essentially being subjected to a real - world clinical test.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues
for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement
for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding
for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell
therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications
for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all,
for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other
therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and
efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
However,
for open - minded researchers, the
efficacy of repartive
therapy is still open to scientific investigation.
For the same reason, it is not easy to prove treatment efficacy by means of controlled, randomized studies, the «gold standard» for evaluating new therapi
For the same reason, it is not easy to prove treatment
efficacy by means
of controlled, randomized studies, the «gold standard»
for evaluating new therapi
for evaluating new
therapies.
Countless studies have established the
efficacy of cognitive behavioral
therapy (CBT)
for many manifestations
of depression and anxiety.
The CO-STAR (Hepatitis C Patients on Opioid Substitution
Therapy Antiviral Response) trial sought to evaluate the
efficacy and safety
of elbasvir - grazoprevir
for injection drug users.
«Our findings point to the importance
of physicians counseling their patients regarding the potential harms
of smoking interfering with the
efficacy of therapies and
for increased risks
of side effects.»
Dr. Rassool says that a clinical trial is planned to test whether low doses
of a DNMT inhibitor, decitabine, and an investigational PARP inhibitor, talazoparib, can be safely combined and whether this
therapy shows
efficacy for AML patients, especially those who can not receive intensive chemotherapy, whose leukemia is resistant to treatment, or who have experienced a relapse after treatment.
In addition, the NFL should convene an independent committee
of medical professionals, without ties to the NFL or any
of its teams, to evaluate the safety and
efficacy of the
therapies, establishing a set
of criteria
for what is considered «safe» and «effective,» the authors said.
«We hope that this assessment
of the
efficacy of currently available migraine
therapies helps patients and their physicians utilize treatments that are the most appropriate
for them,» said Dr. Silberstein.
«These findings do not only contribute to new insights on the effects
of anti-estrogen but also the potential
of using miRNA
for monitoring drug
efficacy and
for future RNA - based
therapy developments.
«If we are able to show
efficacy in non-human primates, we will begin work with the FDA to get approval
for the use
of this viral gene
therapy in diabetic patients, both type 1 and type 2,» Gittes says.
Researchers in New Zealand studied 206 OA patients
for two years to measure the
efficacy of adding regular physical exercise, manual
therapy, or a combination
of both
therapies to standard care, versus continuing usual medical care
for OA alone.
Two new phase III clinical trials investigating the
efficacy and safety
of bitopertin, a glycine uptake inhibitor considered to be a promising new add - on
therapy for treating negative symptoms in schizophrenia, failed to show a benefit
of the drug over placebo.
If these preclinical studies are successful, the researchers plan to further develop their CAR T cell
therapy and test its safety and
efficacy for different types
of metastatic cancer in upcoming clinical trials.
Fischer, in 2000, reported demonstrating the clinical
efficacy of gene
therapy for the first time, using blood stem cells to treat a fatal genetic disorder called X-linked severe combined immunodeficiency.
«The first year results from the CoreValve US Pivotal Trial support the safety and
efficacy of this
therapy in patients unsuitable
for surgical aortic valve replacement,» said lead investigator Steven Yakubov, MD..
The results from our new study suggest that entinostat may enhance the anti-tumor
efficacy of PD - 1 targeted
therapy through MDSC targeting, potentially providing an effective combination treatment approach
for patients with solid tumors, including lung and renal cell carcinoma.»
Scientists at the Universitat Autònoma de Barcelona (UAB) and the Catalan Institute
for Nanoscience and Nanotechnology (ICN2) have developed a nanoencapsulation system with a liposome coating in order to increase the
efficacy of bacteriophages in oral phage
therapy.
For very rare diseases such as WAS, multicenter clinical trials are the only effective way
of proving the safety and
efficacy of gene
therapy and having it rapidly approuved and made available to all patients.
French teams from CIC Biothérapie (AP - HP / Inserm), from pediatric hematology department
of Necker Hospital
for Children (AP - HP), led by Marina Cavazzana, Salima Hacein Bey Albina and Alain Fischer and from Genethon led by Anne Galy (Genethon / Inserm UMR - S951), and English teams from UCL Institute
of Child Health and Great Ormond Street Hospital in London led by Adrian Thrasher and Bobby Gaspar demonstrated the
efficacy of gene
therapy treatment
for Wiskott - Aldrich Syndrome (WAS).
Researchers explained that this difference may be due, in part, to a selection bias where healthier patients were treated with surgery, and they underscored the need
for a controlled clinical trial with matched patients receiving each treatment first - line to compare the
efficacy of these
therapies.
The newly published PLOS ONE study assessed the long - term
efficacy of the
therapy and demonstrated that a single gene
therapy treatment led to prolonged production
of VNA in blood and protected the mice from subsequent exposures to C. botulinum toxin
for up to several months.
«
Efficacy of new gene
therapy approach
for toxin exposures shown in mouse study.»
As this is the first report on this PTH
therapy for ischemic stroke
for the demonstration
of the
efficacy and feasibility, PTH treatment was initiated at 1 hr after stroke followed by repeated administrations
for 6 days.
A Randomized, Phase III Trial to Evaluate The
Efficacy and Safety
of MK - 3475 (Pembrolizumab) as Adjuvant
Therapy for Triple Receptor - Negative Breast Cancer with ≥ 1 cm Residual Invasive Cancer or Positive Lymph Nodes (yPN +) After Neoadjuvant Chemotherapy
He has co-authored more than 100 scientific papers, abstracts, and letters examining the
efficacy, safety and effects
of drug
therapies for cancer.
In line with the objectives
of the International Rare Disease Research Consortium (IRDiRC), we aim to develop novel tools that will allow to make more accurate diagnoses, predict the disease course and the
efficacy of available treatments, and help developing new and better
therapies for rare kidney diseases.
Researchers are examining the
efficacy of mindfulness - based cognitive
therapy for improving emotional and behavioral problems following brain injury, such as aggression, anxiety, and depression.
ViaCyte's VC - 01 ™ product candidate, a first - in - class cell replacement
therapy for the treatment
of type 1 diabetes, is currently being evaluated in a Phase 1/2 trial called STEP ONE, or Safety, Tolerability, and
Efficacy of VC - 01 Combination Product in Type One Diabetes.
Paris, France, April 3, 2018, 5.35 pm CET — GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA - PME eligible), a biopharma company focused on discovering and developing innovative gene
therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced topline results from the REVERSE Phase III clinical trial evaluating the safety and
efficacy of a single intravitreal injection
of GS010 (rAAV2 / 2 - ND 4) in 37 subjects whose visual loss due to 11778 - ND4 Leber Hereditary Optic Neuropathy (LHON) commenced between 6 and 12 months prior to study treatment.
Ultimately, we use all this information to establish innovative culture techniques
for generating unlimited neural stem cell sources
for the derivation
of specific types
of clinically relevant neuronal or glial cells,
for their use in disease modelling and drug discovery platforms, and towards refining their
efficacy for future cell replacement - based
therapy.
Clinical Applications and Bioprocessing Strategies Fundamentally, gene
therapy should exceed the
efficacy of existing therapeutic approaches and provide therapeutic strategies
for unmet medical needs.
Scientists from Emulate and Roche form innovative partnership to use Organ - Chips
for testing
of efficacy and safety
of new antibody therapeutics and combination
therapies
Lysogene collaborates with University
of Massachusetts Medical School (UMMS)
for pre-clinical
efficacy studies
of innovative AAV - based gene
therapy approaches in the GM1 gangliosidosis mouse model.
Despite the expansion
of genetic profiling, there remains a large percentage
of patients
for whom no biomarkers
of drug
efficacy are detected or who become refractory to their targeted
therapy or chemotherapy regimen.
Dr. Jain's nominators note that, in sum, his work has provided ``... unprecedented molecular, cellular, anatomical and functional insights into the vascular pathophysiology
of tumors,
for proposing the seminal hypothesis that antiangiogenic
therapy can «normalize» the aberrant vasculature and microenvironment
of tumors and thereby improve both delivery and
efficacy of treatment
of solid tumors.»
Though it is among the most common types
of therapy, there is less evidence
for its
efficacy than there is
for CBT.
Remarkable
efficacy of thermal
therapy for sjogren syndrome.
For the same reasons of safety and efficacy, we only use bioidentical hormones for estrogen replacement thera
For the same reasons
of safety and
efficacy, we only use bioidentical hormones
for estrogen replacement thera
for estrogen replacement
therapy.
For a legitimate place where to get legal injectable HGH for sale online, you should contact a medical facility with the sole practice of hormone replacement therapy, where you will not only get safe and high - quality medicine, but you will also receive a full treatment program that includes the monitoring of treatment by qualified medical personnel (yet another means of ensuring both safety and efficac
For a legitimate place where to get legal injectable HGH
for sale online, you should contact a medical facility with the sole practice of hormone replacement therapy, where you will not only get safe and high - quality medicine, but you will also receive a full treatment program that includes the monitoring of treatment by qualified medical personnel (yet another means of ensuring both safety and efficac
for sale online, you should contact a medical facility with the sole practice
of hormone replacement
therapy, where you will not only get safe and high - quality medicine, but you will also receive a full treatment program that includes the monitoring
of treatment by qualified medical personnel (yet another means
of ensuring both safety and
efficacy).
The study measured the
efficacy of massage
therapy treatment by utilizing the Alcohol Withdrawal Scale (AWS), a tool
for measuring physiological alcohol withdrawal symptoms such as one - minute radial pulse rate and respiration rate at the beginning and end
of each 15 - minute massage or rest interval.
For more, see The effect of Saccharomyces boulardii on Candida albicans - infected intestinal cell lines Caco - 2 and Intestin - 407, and Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorde
For more, see The effect
of Saccharomyces boulardii on Candida albicans - infected intestinal cell lines Caco - 2 and Intestin - 407, and
Efficacy and safety
of the probiotic Saccharomyces boulardii
for the prevention and therapy of gastrointestinal disorde
for the prevention and
therapy of gastrointestinal disorders.
Pelvic Floor Physical
Therapy is effective
for prolapses in stages 1 and 2 and its focus is the relief
of pressure by means
of hypopressive abdominal exercises, and the improvement
of tone and endurance
of the pelvic floor muscles to help maintain the position
of the organs in the pelvis (1:
Efficacy of pelvic floor muscle training and hypopressive exercises
for treating pelvic organ prolapse in women: randomized controlled trial).
This one involves testing the
efficacy of capsaicin, an active component
of chili peppers, as a
therapy for otherwise healthy dogs diagnosed with osteoarthritis in an elbow or limb joint.
If you scour veterinary literature, you won't find many double - blind clinical studies on
therapy lasers; however, if you search PubMed
for clinical evidence on the
efficacy of laser
therapy, you'll be inundated with thousands
of articles on its various applications — ranging from its basic usages to the vastly more extreme and bizarre: things like treating diabetic ulcers, traumatic brain injuries, peripheral nervous system failures, mal - union fractures, and more.
Regularly scheduled laboratory work is important to monitor
for efficacy of methimazole
therapy and to identify any possible adverse effects.
WASHINGTON, D.C., June 3 — Help
for the more than 12,000 children diagnosed with cancer each year in the United States, in the form
of an innovative, four - legged
therapy, is about to be rigorously studied to determine its
efficacy.
Therefore, the purpose
of this study is to examine the
efficacy of stem cell
therapy as a potential treatment
for acute severe spinal cord injuries in dogs.